Commerzbank Aktiengesellschaft’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-104,000
Closed -$25K 1076
2019
Q2
$25K Buy
+104,000
New +$9.88M ﹤0.01% 1025
2018
Q2
Sell
-70,000
Closed -$113K 1025
2018
Q1
$113K Buy
70,000
+1,200
+2% +$115K ﹤0.01% 880
2017
Q4
$33K Buy
+68,800
New +$7.76M ﹤0.01% 889
2016
Q1
Sell
-40,000
Closed -$4.79M 1215
2015
Q4
$4.79M Hold
40,000
0.04% 315
2015
Q3
$4.33M Sell
40,000
-10,000
-20% -$1.24M 0.03% 305
2015
Q2
$5.79M Sell
50,000
-92,500
-65% -$10.6M 0.03% 326
2015
Q1
$16.4M Sell
142,500
-17,000
-11% -$2.03M 0.1% 141
2014
Q4
$17.8M Buy
159,500
+12,500
+9% +$1.32M 0.11% 153
2014
Q3
$13.9M Buy
147,000
+125,000
+568% +$11.3M 0.06% 249
2014
Q2
$1.89M Sell
22,000
-58,000
-73% -$4.41M 0.01% 718
2014
Q1
$5.58M Sell
80,000
-50,000
-38% -$3.96M 0.02% 411
2013
Q4
$9.88M Buy
130,000
+80,000
+160% +$6.33M 0.05% 265
2013
Q3
$3.85M Hold
50,000
0.02% 546
2013
Q2
$2.92M Buy
+50,000
New +$3.01M 0.01% 681

Other funds holding CELG

Commerzbank Aktiengesellschaft's CELG Position: Q4 2019 in Review

Commerzbank Aktiengesellschaft sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 349,448 shares — an estimated $34.7M sold.

Commerzbank Aktiengesellschaft first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $85.1M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Commerzbank Aktiengesellschaft reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 349,448 Celgene Corp shares in Q4 2019, an estimated $34.7M.
  • Commerzbank Aktiengesellschaft first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Commerzbank Aktiengesellschaft's Celgene Corp position peaked at $85.1M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2019, filed 17 Jan 2020.